// App-Quantinova.ai

2505 : Expression Profiling for MEIS1 and HOXA9/10 Identifies an Increased Incidence of MLL Rearrangements in T-ALL: A Children's Oncology Group Study.

Researchers

Presenter

  • Richard C. Harvey

Principal Investigators

  • I-Ming Chen

  • Barbara Asselin

  • Naomi Winick

  • William L. Carroll

  • Richard S. Larson

  • Kimberly P. Dunsmore

  • Stuart S. Winter

  • Cheryl L Willman

  • Nyla A. Heerema

  • Andrew J. Carroll

  • Meenakshi Devidas

  • Mignon L. Loh

  • Stephen P. Hunger

  • Elizabeth Raetz

  • Charles G Mullighan

Medical Centers

  • Cell Pathology Laboratories, University of New Mexico, Albuquerque, NM, USA,

  • Department of Pediatrics, Univ of Rochester School of Medicine, Golisano Children's Hospital at URMC, Rochester, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Chondroitin Sulfate Proteoglycan 4

  • Homeobox A9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved